Lexeo Gene Therapy Trial for ACM

Thank you for your interest in participating in the Lexeo Gene Therapy for ACM

Thank you for your interest in participating in the Lexeo Gene Therapy for ACM.

Thank you for your interest in participating in the Lexeo HEROIC-PKP2 Gene Therapy Trial for PKP2-ARVC.

Please CLICK HERE ([email protected] ) to send an email to the patient advocacy contact at Lexeo. They will connect you directly with the trial site coordinator of your choice.

If you have any questions, or have any trouble getting in contact with someone, please don’t hesitate to reach out to us at SADS – you can reply to this email, send an email to [email protected], or call or text 801-948-0654.

You can read more information about this trial on ClinicialTrials.gov.